×
About 856 results

ALLMedicine™ Oncology Treatment Center

Research & Reviews  353 results

Rhabdomyosarcoma.
https://doi.org/10.1002/pbc.28254
Pediatric Blood & Cancer; Yechieli RL, Mandeville HC et. al.

Apr 5th, 2021 - Rhabdomyosarcoma is a heterogeneous disease both in presentation and histology. Improvements in a multimodality therapy resulted in the improved overall survival for patients with a low-risk and intermediate-risk disease but not for patients with ...

Reducing distress and depression in cancer patients during survivorship.
https://doi.org/10.1002/pon.5683
Psycho-oncology Molinaro J, Banerjee A et. al.

Apr 2nd, 2021 - Distress and depression are prevalent in cancer patients throughout survivorship and are associated with adverse outcomes. This study examines the association between outpatient psycho-oncology treatment and distress and depression in cancer patie...

Partnering with healthcare facilities to understand psychosocial distress screening pra...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968218
BMC Health Services Research; Ng D, Gallaway MS et. al.

Mar 18th, 2021 - We sought to understand barriers and facilitators to implementing distress screening (DS) of cancer patients to inform and promote uptake in cancer treatment facilities. We describe the recruitment and data collection challenges and recommendation...

Rigid and Deformable Image Registration for Radiation Therapy: A Self-Study Evaluation ...
https://doi.org/10.1016/j.prro.2021.02.007
Practical Radiation Oncology; Rong Y, Rosu-Bubulac M et. al.

Mar 4th, 2021 - The registration of multiple imaging studies to radiation therapy CT simulation, including MRI, PET-CT, and SPECT is a widely used strategy in Radiation Oncology treatment planning, and these registrations have valuable roles in image guidance, do...

How to Reduce the No-Show Rate in the Psychiatric Oncology Clinic: Clinical Safety and ...
https://doi.org/10.1176/appi.ps.201900480
Psychiatric Services (Washington, D.C.); Rashid A, Rickman K et. al.

Jan 20th, 2021 - Mental health stability among patients with cancer improves adherence to oncology treatment, contributing to better outcomes. In a comprehensive cancer center, the no-show rate for the psychiatric oncology clinic was higher than that of any other ...

see more →

Guidelines  31 results

KDIGO Controversies Conference on onco-nephrology: understanding kidney impairment and ...
https://doi.org/10.1016/j.kint.2020.06.046
Kidney International; Porta C, Bamias A et. al.

Oct 31st, 2020 - The association between kidney disease and cancer is multifaceted and complex. Persons with chronic kidney disease (CKD) have an increased incidence of cancer, and both cancer and cancer treatments can cause impaired kidney function. Renal issues ...

Investigating MET Exon 14 Mutations in Patients With NSCLC
https://www.targetedonc.com/view/investigating-met-exon-14-mutations-in-patients-with-nsclc

May 28th, 2020 - Mark M. Awad, MD, PhD, clinical director of the Thoracic Oncology Treatment Center at Dana-Farber Cancer Institute and assistant professor of Medicine at Harvard Medical School, discusses the characterization of patients with non–small cell lung c...

Standardizing Normal Tissue Contouring for Radiation Therapy Treatment Planning: Executive summary of an ASTRO Consensus Paper
https://www.practicalradonc.org/article/S1879-8500(18)30353-9/abstract
Wright,J.,et al

Jan 20th, 2019 - Standardization improves patient safety, efficiency, and accuracy in radiation oncology treatment. This consensus guidance represents an ASTRO quality initiative to provide recommendations for the standardization of normal tissue contouring perfor...

ASTRO Consensus Statement on Standardizing Normal Tissue Contouring for Radiation Therapy Treatment Planning: Executive Summary
https://www.astro.org/Patient-Care-and-Research/Clinical-Practice-Statements/Contouring-Consensus-Guidance-Document

Jan 20th, 2019 - This document provides tabled recommendations for normal tissues contouring during external beam treatment planning for each anotomical site in all definitive cases and those that should be considered in specific clinical scenarios. Additionally, ...

Morbidity and Mortality Rates Following Cytoreductive Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy Compared With Other High-Risk Surgical Oncology Procedures
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2720582
Foster,J.

Jan 10th, 2019 - Comparative analysis revealed CRS/HIPEC to be safe, often safer across the spectrum of NSQIP safety metrics when compared with similar-risk oncologic procedures. Patient selection was important in achieving observed outcomes. High complication rat...

see more →

Drugs  2 results see all →

Clinicaltrials.gov  431 results

Rhabdomyosarcoma.
https://doi.org/10.1002/pbc.28254
Pediatric Blood & Cancer; Yechieli RL, Mandeville HC et. al.

Apr 5th, 2021 - Rhabdomyosarcoma is a heterogeneous disease both in presentation and histology. Improvements in a multimodality therapy resulted in the improved overall survival for patients with a low-risk and intermediate-risk disease but not for patients with ...

Reducing distress and depression in cancer patients during survivorship.
https://doi.org/10.1002/pon.5683
Psycho-oncology Molinaro J, Banerjee A et. al.

Apr 2nd, 2021 - Distress and depression are prevalent in cancer patients throughout survivorship and are associated with adverse outcomes. This study examines the association between outpatient psycho-oncology treatment and distress and depression in cancer patie...

Partnering with healthcare facilities to understand psychosocial distress screening pra...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968218
BMC Health Services Research; Ng D, Gallaway MS et. al.

Mar 18th, 2021 - We sought to understand barriers and facilitators to implementing distress screening (DS) of cancer patients to inform and promote uptake in cancer treatment facilities. We describe the recruitment and data collection challenges and recommendation...

Rigid and Deformable Image Registration for Radiation Therapy: A Self-Study Evaluation ...
https://doi.org/10.1016/j.prro.2021.02.007
Practical Radiation Oncology; Rong Y, Rosu-Bubulac M et. al.

Mar 4th, 2021 - The registration of multiple imaging studies to radiation therapy CT simulation, including MRI, PET-CT, and SPECT is a widely used strategy in Radiation Oncology treatment planning, and these registrations have valuable roles in image guidance, do...

Florida Cancer Center Founder Faces Criminal Trial for Conspiracy
https://www.medscape.com/viewarticle/945273

Feb 3rd, 2021 - The criminal trial of William Harwin, MD, founder and former president of Florida Cancer Specialists, a multisite practice headquartered in Fort Myers, is set for June, according to federal documents reviewed by Medscape Medical News. Harwin is ch...

see more →

News  39 results

Florida Cancer Center Founder Faces Criminal Trial for Conspiracy
https://www.medscape.com/viewarticle/945273

Feb 3rd, 2021 - The criminal trial of William Harwin, MD, founder and former president of Florida Cancer Specialists, a multisite practice headquartered in Fort Myers, is set for June, according to federal documents reviewed by Medscape Medical News. Harwin is ch...

'Long-Running' Conspiracy: Cancer Center's Ex-Top Doc Indicted
https://www.staging.medscape.com/viewarticle/938197

Sep 27th, 2020 - William Harwin, MD, founder and former president of Florida Cancer Specialists, a large multisite practice, has been indicted by a federal grand jury for conspiring to restrict patient choice and allocate medical and radiation oncology treatment i...

'Long-Running' Conspiracy: Cancer Center's Ex-Top Doc Indicted
https://www.medscape.com/viewarticle/938197

Sep 27th, 2020 - William Harwin, MD, founder and former president of Florida Cancer Specialists, a large multisite practice, has been indicted by a federal grand jury for conspiring to restrict patient choice and allocate medical and radiation oncology treatment i...

Investigating MET Exon 14 Mutations in Patients With NSCLC
https://www.targetedonc.com/view/investigating-met-exon-14-mutations-in-patients-with-nsclc

May 28th, 2020 - Mark M. Awad, MD, PhD, clinical director of the Thoracic Oncology Treatment Center at Dana-Farber Cancer Institute and assistant professor of Medicine at Harvard Medical School, discusses the characterization of patients with non–small cell lung c...

Oncologists agree with AI treatment decisions about half the time
https://www.mdedge.com/fedprac/avaho/article/206866/breast-cancer/oncologists-agree-ai-treatment-decisions-about-half-time?channel=263
Will Pass

Aug 22nd, 2019 - When it comes to treatment recommendations for high-risk breast cancer, oncologists agree with a leading artificial intelligence platform about half the time, according to investigators. In the first study of its kind, involving 10 Chinese oncolog.

see more →